Bulletin
Investor Alert

New York Markets Open in:

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 25, 2021, 7:59 p.m.

/zigman2/quotes/203149337/composite

$

575.50

Change

-0.70 -0.12%

Volume

Volume 81,319

Quotes are delayed by 20 min

/zigman2/quotes/203149337/composite

Previous close

$ 572.36

$ 576.20

Change

+3.84 +0.67%

Day low

Day high

$569.53

$578.73

Open

52 week low

52 week high

$441.00

$686.62

Open

Insider Actions for Regeneron Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/01/2021 Arthur Frederick Ryan
Director
2   Disposition at $577.27 per share. 1,154
10/01/2021 Arthur Frederick Ryan
Director
12   Disposition at $576.34 per share. 6,916
10/01/2021 Arthur Frederick Ryan
Director
4   Disposition at $575.41 per share. 2,301
10/01/2021 Arthur Frederick Ryan
Director
5   Disposition at $574.33 per share. 2,871
10/01/2021 Arthur Frederick Ryan
Director
7   Disposition at $573.54 per share. 4,014
10/01/2021 Arthur Frederick Ryan
Director
1   Disposition at $572.32 per share. 572
10/01/2021 Arthur Frederick Ryan
Director
2   Disposition at $571.88 per share. 1,143
10/01/2021 Arthur Frederick Ryan
Director
9   Disposition at $570.37 per share. 5,133
10/01/2021 Arthur Frederick Ryan
Director
15   Disposition at $569.54 per share. 8,543
10/01/2021 Arthur Frederick Ryan
Director
1   Disposition at $568.03 per share. 568
10/01/2021 Arthur Frederick Ryan
Director
1   Disposition at $567.99 per share. 567
10/01/2021 Arthur Frederick Ryan
Director
10   Disposition at $566.65 per share. 5,666
10/01/2021 Arthur Frederick Ryan
Director
11   Disposition at $565.36 per share. 6,218
10/01/2021 Arthur Frederick Ryan
Director
12   Disposition at $564.47 per share. 6,773
10/01/2021 Arthur Frederick Ryan
Director
3   Disposition at $563.84 per share. 1,691
10/01/2021 Arthur Frederick Ryan
Director
4   Disposition at $562.68 per share. 2,250
10/01/2021 Arthur Frederick Ryan
Director
1   Disposition at $560.51 per share. 560
10/01/2021 Marion McCourt
EVP Commercial
1,000   Disposition at $576.75 per share. 576,750
10/01/2021 Marion McCourt
EVP Commercial
1,000   Derivative/Non-derivative trans. at $342.93 per share. 342,930
09/15/2021 N. Anthony Coles
Director
1,174   Disposition at $664.32 per share. 779,911
09/15/2021 N. Anthony Coles
Director
905   Disposition at $663.73 per share. 600,675
09/15/2021 N. Anthony Coles
Director
3   Disposition at $662.55 per share. 1,987
09/15/2021 N. Anthony Coles
Director
3,344   Disposition at $661.56 per share. 2,212,256
09/15/2021 N. Anthony Coles
Director
448   Disposition at $660.78 per share. 296,029
09/15/2021 N. Anthony Coles
Director
300   Disposition at $659 per share. 197,700
09/15/2021 N. Anthony Coles
Director
935   Disposition at $658.65 per share. 615,837
09/15/2021 N. Anthony Coles
Director
835   Disposition at $657.53 per share. 549,037
09/15/2021 N. Anthony Coles
Director
1,400   Disposition at $656.48 per share. 919,072
09/15/2021 N. Anthony Coles
Director
403   Disposition at $655.14 per share. 264,021
09/15/2021 N. Anthony Coles
Director
800   Disposition at $653.31 per share. 522,648
09/15/2021 N. Anthony Coles
Director
1,101   Disposition at $652.95 per share. 718,897
09/15/2021 N. Anthony Coles
Director
300   Disposition at $651.36 per share. 195,408
09/15/2021 N. Anthony Coles
Director
5,039   Derivative/Non-derivative trans. at $345.47 per share. 1,740,823
09/15/2021 N. Anthony Coles
Director
6,909   Derivative/Non-derivative trans. at $380.95 per share. 2,631,983
09/14/2021 Huda Y. Zoghbi
Director
998   Disposition at $650 per share. 648,700
09/14/2021 Huda Y. Zoghbi
Director
998   Derivative/Non-derivative trans. at $391.92 per share. 391,136
09/13/2021 Michael S. Brown
Director
62   Disposition at $652.26 per share. 40,440
09/13/2021 Michael S. Brown
Director
3,712   Disposition at $651.1 per share. 2,416,883
09/13/2021 Michael S. Brown
Director
1,800   Disposition at $650.4 per share. 1,170,720
09/13/2021 Michael S. Brown
Director
838   Disposition at $649.46 per share. 544,247
09/13/2021 Michael S. Brown
Director
962   Disposition at $648.48 per share. 623,837
09/13/2021 Michael S. Brown
Director
151   Disposition at $647.58 per share. 97,784
09/13/2021 Michael S. Brown
Director
100   Disposition at $646.28 per share. 64,628
09/13/2021 Michael S. Brown
Director
100   Disposition at $645.66 per share. 64,566
09/13/2021 Michael S. Brown
Director
100   Disposition at $644.89 per share. 64,489
09/13/2021 Michael S. Brown
Director
100   Disposition at $643.49 per share. 64,349
09/13/2021 Michael S. Brown
Director
400   Disposition at $642.62 per share. 257,048
09/13/2021 Michael S. Brown
Director
100   Disposition at $641.12 per share. 64,112
09/13/2021 Michael S. Brown
Director
100   Disposition at $640.77 per share. 64,077
09/13/2021 Michael S. Brown
Director
203   Disposition at $639.2 per share. 129,757
09/13/2021 Michael S. Brown
Director
676   Disposition at $638.64 per share. 431,720
09/13/2021 Michael S. Brown
Director
200   Disposition at $637.29 per share. 127,458
09/13/2021 Michael S. Brown
Director
100   Disposition at $636.74 per share. 63,674
09/13/2021 Marc Tessier-Lavigne
Director
139   Disposition at $652.26 per share. 90,664
09/13/2021 Marc Tessier-Lavigne
Director
249   Disposition at $651.54 per share. 162,233
09/13/2021 Marc Tessier-Lavigne
Director
56   Disposition at $650.33 per share. 36,418
09/13/2021 Marc Tessier-Lavigne
Director
124   Disposition at $649.35 per share. 80,519
09/13/2021 Marc Tessier-Lavigne
Director
381   Disposition at $648.25 per share. 246,983
09/13/2021 Marc Tessier-Lavigne
Director
425   Disposition at $647.39 per share. 275,140
09/13/2021 Marc Tessier-Lavigne
Director
354   Disposition at $646.24 per share. 228,768
09/13/2021 Marc Tessier-Lavigne
Director
61   Disposition at $645.21 per share. 39,357
09/13/2021 Marc Tessier-Lavigne
Director
844   Disposition at $644.52 per share. 543,974
09/13/2021 Marc Tessier-Lavigne
Director
1,549   Disposition at $643.33 per share. 996,518
09/13/2021 Marc Tessier-Lavigne
Director
1,645   Disposition at $642.54 per share. 1,056,978
09/13/2021 Marc Tessier-Lavigne
Director
952   Disposition at $641.56 per share. 610,765
09/13/2021 Marc Tessier-Lavigne
Director
981   Disposition at $640.61 per share. 628,438
09/13/2021 Marc Tessier-Lavigne
Director
1,260   Disposition at $639.45 per share. 805,707
09/13/2021 Marc Tessier-Lavigne
Director
2,098   Disposition at $638.46 per share. 1,339,489
09/13/2021 Marc Tessier-Lavigne
Director
816   Disposition at $637.71 per share. 520,371
09/13/2021 Marc Tessier-Lavigne
Director
816   Disposition at $636.64 per share. 519,498
09/13/2021 Huda Y. Zoghbi
Director
2   Disposition at $651.1 per share. 1,302
09/13/2021 Michael S. Brown
Director
3,612   Derivative/Non-derivative trans. at $413.33 per share. 1,492,947
09/13/2021 Michael S. Brown
Director
3,613   Derivative/Non-derivative trans. at $413.33 per share. 1,493,361
09/13/2021 Michael S. Brown
Director
2,479   Derivative/Non-derivative trans. at $380.95 per share. 944,375
09/13/2021 Marc Tessier-Lavigne
Director
4,250   Derivative/Non-derivative trans. at $273.67 per share. 1,163,097
09/13/2021 Marc Tessier-Lavigne
Director
4,250   Derivative/Non-derivative trans. at $273.67 per share. 1,163,097
09/13/2021 Marc Tessier-Lavigne
Director
4,250   Derivative/Non-derivative trans. at $273.67 per share. 1,163,097
09/13/2021 Huda Y. Zoghbi
Director
2   Derivative/Non-derivative trans. at $391.92 per share. 783
09/10/2021 Joseph L. Goldstein
Director
2,479   Disposition at $650 per share. 1,611,350
09/10/2021 Joseph L. Goldstein
Director
2,479   Derivative/Non-derivative trans. at $380.95 per share. 944,375
09/01/2021 Arthur Frederick Ryan
Director
2   Disposition at $684.31 per share. 1,368
09/01/2021 Arthur Frederick Ryan
Director
1   Disposition at $683.79 per share. 683
09/01/2021 Arthur Frederick Ryan
Director
4   Disposition at $682.32 per share. 2,729
09/01/2021 Arthur Frederick Ryan
Director
2   Disposition at $681.48 per share. 1,362
09/01/2021 Arthur Frederick Ryan
Director
4   Disposition at $680.53 per share. 2,722
09/01/2021 Arthur Frederick Ryan
Director
3   Disposition at $679.55 per share. 2,038
09/01/2021 Arthur Frederick Ryan
Director
10   Disposition at $678.43 per share. 6,784
09/01/2021 Arthur Frederick Ryan
Director
3   Disposition at $677.7 per share. 2,033
09/01/2021 Arthur Frederick Ryan
Director
21   Disposition at $676.54 per share. 14,207
09/01/2021 Arthur Frederick Ryan
Director
7   Disposition at $675.7 per share. 4,729
09/01/2021 Arthur Frederick Ryan
Director
14   Disposition at $674.51 per share. 9,443
09/01/2021 Arthur Frederick Ryan
Director
19   Disposition at $673.56 per share. 12,797
09/01/2021 Arthur Frederick Ryan
Director
10   Disposition at $672.75 per share. 6,727
09/01/2021 Marion McCourt
EVP Commercial
1,000   Disposition at $674.72 per share. 674,720
09/01/2021 Marion McCourt
EVP Commercial
1,000   Derivative/Non-derivative trans. at $342.93 per share. 342,930
08/31/2021 Robert E. Landry
EVP Finance CFO
917   Derivative/Non-derivative trans. at $675.03 per share. 619,002
08/31/2021 Robert E. Landry
EVP Finance CFO
1,000   Derivative/Non-derivative trans. at $555.67 per share. 555,670
08/30/2021 George L. Sing
Director
300   Disposition at $672 per share. 201,600
08/30/2021 George L. Sing
Director
250   Disposition at $670 per share. 167,500
08/30/2021 George L. Sing
Director
500   Disposition at $675 per share. 337,500
08/30/2021 George L. Sing
Director
500   Disposition at $670 per share. 335,000
08/27/2021 Christine A. Poon
Director
112   Disposition at $672.27 per share. 75,294
08/27/2021 Christine A. Poon
Director
1,737   Disposition at $671.49 per share. 1,166,378
08/27/2021 Christine A. Poon
Director
3,447   Disposition at $670.48 per share. 2,311,144
08/27/2021 Christine A. Poon
Director
2,235   Disposition at $669.59 per share. 1,496,533
08/27/2021 Christine A. Poon
Director
603   Disposition at $668.33 per share. 403,002
08/27/2021 Christine A. Poon
Director
2,150   Disposition at $667.37 per share. 1,434,845
08/27/2021 Christine A. Poon
Director
1,118   Disposition at $666.7 per share. 745,370
08/27/2021 Christine A. Poon
Director
538   Disposition at $665.33 per share. 357,947
08/27/2021 Christine A. Poon
Director
700   Disposition at $664.42 per share. 465,094
08/27/2021 Christine A. Poon
Director
2,260   Disposition at $663.51 per share. 1,499,532
08/27/2021 Christine A. Poon
Director
100   Disposition at $662.62 per share. 66,262
08/27/2021 Christine A. Poon
Director
15,000   Derivative/Non-derivative trans. at $57.11 per share. 856,650
08/26/2021 George L. Sing
Director
150   Disposition at $672 per share. 100,800

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
29 Purchases
196 Sales
597,159
763,114
Last 6 months
41 Purchases
247 Sales
923,694
1,211,222
Last 12 months
71 Purchases
313 Sales
1,705,671
1,586,347

Officers and Executives

Dr. P. Roy Vagelos
Chairman
Dr. Leonard S. Schleifer
Co-President, Chief Executive Officer & Director
Dr. George Damis Yancopoulos
Co-President, Director & Chief Scientific Officer
Ms. Patrice Gilooly
Senior VP-Quality Assurance & Operations
Mr. Robert E. Landry
Chief Financial Officer & Executive VP-Finance
Dr. Andrew J. Murphy
Executive Vice President-Research
Mr. Bob McCowan
Chief Information Officer & Senior VP-IT
Dr. Neil Stahl
Executive VP-Research & Development
Dr. David Weinreich
Senior Vice President-Global Clinical Development
Mr. Nouhad Husseini
Vice President-Business Development
Mr. Gerald Underwood
Senior Vice President-Technical Operations
Dr. Kerry K. Reinertsen
Senior Vice President-Strategic Alliances
Mr. Daniel P. Van Plew
EVP, GM-Industrial Operations & Product Supply
Ms. Beth F. Levine
Chief Compliance Officer & Senior Vice President
Dr. Alan Shuldiner
Vice President-Translational Genetics
Ms. Marion McCourt
Senior Vice President & Commercial Head
Mr. Christopher Robert Fenimore
Senior VP, Head-Accounting & Controller
Mr. Justin Holko
Head-Investor Relations
Ms. Sally A. Paull
Senior Vice President-Human Resources
Mr. Joseph J. LaRosa
Secretary, Executive VP & General Counsel
Ms. Maya Bermingham
Senior VP, Public Policy & Government Affairs
Dr. Ned Braunstein
SVP-Regulatory Affairs & Global Patient Safety
Dr. Michael S. Brown
Independent Director
Dr. Joseph L. Goldstein
Independent Director
Mr. George L. Sing
Independent Director
Mr. Arthur Frederick Ryan
Independent Director
Ms. Christine A. Poon
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Bonnie L. Bassler
Independent Director
Dr. Huda Y. Zoghbi
Independent Director
Dr. N. Anthony Coles
Independent Director
Link to MarketWatch's Slice.